Showing results (811-820 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|November 29, 2012
Nutlin-3, a small-molecule MDM2 inhibitor, sensitizes Caki cells to TRAIL-induced apoptosis through p53-mediated PUMA upregulation and ROS-mediated DR5 upregulationEun Jung Park, Kyeong Sook Choi, Young Hyun Yoo, et al.Anti-Cancer Drugs|November 29, 2012
Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemiaKatalin Csordas, Marta Hegyi, Oliver T Eipel, et al.Anti-Cancer Drugs|May 31, 2012
Paclitaxel and cetuximab combination efficiency after the failure of a platinum-based chemotherapy in recurrent/metastatic head and neck squamous cell carcinomaJulien Péron, Philippe Ceruse, Emilie Lavergne, et al.Anti-Cancer Drugs|September 16, 2014
A retrospective study of paclitaxel combining nedaplatin chemotherapy for esophageal cancerJianping Du, Changlu Hu, Yuliu Zhang, et al.Anti-Cancer Drugs|September 18, 2014
Curcumin inhibits aerobic glycolysis and induces mitochondrial-mediated apoptosis through hexokinase II in human colorectal cancer cells in vitroKe Wang, Hua Fan, Qingsen Chen, et al.Anti-Cancer Drugs|September 23, 2014
Cytotoxic and antiangiogenic paclitaxel solubilized and permeation-enhanced by natural product nanoparticlesZhijun Liu, Fang Zhang, Gar Yee Koh, et al.Anti-Cancer Drugs|October 12, 2014
Gc-protein-derived macrophage activating factor counteracts the neuronal damage induced by oxaliplatinGabriele Morucci, Jacopo J V Branca, Massimo Gulisano, et al.Anti-Cancer Drugs|October 12, 2014
Clinical outcomes in pancreatic adenocarcinoma associated with BRCA-2 mutationOjas Vyas, Keith Leung, Leslie Ledbetter, et al.Anti-Cancer Drugs|December 17, 2013
Taxanes as radiosensitizersEncouse B Golden, Silvia C Formenti, Peter B SchiffAnti-Cancer Drugs|May 31, 2013
Near-complete pathological response with preoperative chemotherapy in a patient with metaplastic breast carcinomaArya Amini, Jane Kakkis, Richard Reitherman, et al.Pageof 464